TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
VIR

Vir Biotechnology Inc

Healthcare · Biotechnology

11.20$ +5.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow VIR
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
-44,551.0% -10,840.6% -18,232.3% -250.0% -4.3% 102.9% -903.7% -601.5% -571.5%
289.9% 317.5% 635.3% 7.1% 0.5% 0.4% 22.6% 19.6% 30.9%
3,209.4% 582.1% 1,226.3% 36.1% 7.6% 6.3% 129.2% 105.7% 71.6%
-1,223.5% 753.2% 4,547.1% 59.2% 4.2% 29.4% – – –
3,263.1% 1,439.4% 1,153.9% 38.7% -57.4% 41.2% -353.4% -113.2% -32.7%
1,840.3% 943.8% 1,257.4% 8.6% 2.0% 4.2% 25.0% 9.8% 7.0%
-20,130.2% -6,963.2% -36,027.8% -12.9% -12.9% -73.9% 191.1% 673.0% 452.7%
0.0% 0.0% – – – – – – –
0.0% 1,709.4% -0.4% 428.5% 1.4% 0.2% – – –
743.0% 127.5% 155.7% -0.3% 0.0% 0.0% -0.3% – –
182,001.3% 2,877.6% 63,184.8% 693.3% 9.2% 2.2% 8.6% 5.9% 5.5%
117,320.1% -14,926.2% 8,924.6% 430.4% -8.0% 31.2% -703.7% 77.4% -113.2%
-46,391.3% -11,784.3% -19,489.7% -258.6% -6.3% 98.7% -928.7% -611.4% -578.5%

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?